INSIGHTS ON CLINICAL TRIAL PARTNERING

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• The Future Of Patient Experience: Lessons From GLP-1 Studies

  Improve adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.

• The Ten Commandments Of Vendor Selection

  Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.

• The Stakeholder Impact of Centralized Trial Services

  Real‑world experiences show how centralizing logistics and payments streamlines coordination, reduces site burden, and improves trial execution.

• Key Risk Areas that Can Derail Clinical Trials with Ocular Endpoints

  1/15/2025

  By embracing point-of-need models and strategic collaborations, sponsors and CROs can streamline ophthalmic trials and maximize ROI while advancing sight-saving therapies.

• Why Site Training Still Slows Site Activation

  5/11/2026

  Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.

• Harness An Adept IRB's Expertise To Streamline Study Design

  10/2/2026

  An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.

• Specialized Site Network For Early-Phase Oncology Success

  10/2/2025

  Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Yet, too often, the operational burden falls on clinical sites―already overworked and stretched thin. Within large, volume-driven CRO networks, this creates a system that prioritizes scale over quality, offering minimal site support, delaying timelines, and ultimately compromising trial outcomes.

• The Role Of Company Culture In FSP Partnerships

  8/1/2025

  This piece explores intentional culture-building as a strategic asset in FSP engagements, transforming transactional relationships into enduring, high-performing partnerships.